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LCK is a tyrosine kinase essential for initiating T-cell antigen receptor (TCR) signaling. A complete 14 
understanding of LCK function is constrained by a paucity of methods to quantitatively study its function 15 
within live cells. To address this limitation, we generated LCK*, in which a key active site lysine is replaced 16 
by a photo-caged equivalent, using genetic code expansion. This enabled fine temporal and spatial control 17 
over kinase activity, allowing us to quantify phosphorylation kinetics in situ using biochemical and imaging 18 
approaches. We find that auto-phosphorylation of the LCK active site loop is indispensable for its catalytic 19 
activity and that LCK can stimulate its own activation by adopting a more open conformation, which can 20 
be modulated by point mutations. We then show that CD4 and CD8, the T-cell coreceptors, can enhance 21 
LCK activity, helping to explain their effect in physiological TCR signaling. Our approach also provides 22 




Biological systems rely on enzymes such as kinases to transmit information between the nodes of cell 2 
signaling networks, often to transduce extracellular ligand binding events into intracellular information. An 3 
important example of this is found in T cells, an essential cell-type of our adaptive immune system that can 4 
discriminate between healthy cells and those that are infected by pathogens. Expression of the T-cell antigen 5 
receptor complex (TCR) at the cell surface allows the T cell to probe potentially infected host cells by 6 
scrutinizing their surface for expression of peptide fragments of pathogens presented within the MHC 7 
protein (pMHC). On binding cognate pMHC, a cascade of intracellular signaling is initiated from the TCR 8 
that either leads to the T cell directly killing the infected cells, or instructing other cell-types to do so1.  9 
The most proximal event following pMHC binding is the phosphorylation of the immunoreceptor tyrosine-10 
based activation motifs (ITAMs) in the intracellular tails of the TCR by LCK, a prototypic member of the 11 
SRC-family tyrosine kinases (SFK) that is almost exclusively expressed in T cells2. The phosphorylated 12 
ITAMs then recruit proteins with SRC-homology 2 (SH2) domains such as ZAP70, a cytoplasmic tyrosine 13 
kinase. Bound ZAP70 is phosphorylated by LCK, primarily at tyrosine-319 (Y319) that leads to its 14 
activation and subsequent phosphorylation of downstream effector molecules that drive multiple signaling 15 
pathways. LCK kinase activity is therefore crucial in translating the TCR–pMHC interaction into 16 
downstream signals in T cells. Understanding how the kinase activity of LCK is controlled within T cells 17 
at the molecular level is important not just for our fundamental understanding of TCR signal transduction 18 
but for suggesting new means by which its activity could be modulated therapeutically, given the 19 
deleterious effect of T-cell mediated auto-immunity3 and its aberrant regulation in certain leukemias4,5.  20 
Previous studies have shown that the SH2 domain of LCK can bind intramolecularly to a phosphorylated 21 
residue (Y505) at the C-terminus to adopt a closed auto-inhibitory conformation, which is a general feature 22 
of SFK regulatory mechanism6,7. Phosphorylation of Y505 is catalyzed by C-terminal SRC kinase (CSK)8,9 23 
and antagonized primarily by the membrane-bound tyrosine phosphatase CD4510. This modification can 24 
regulate the conformations that LCK can adopt, affecting its activity11–13. Full activation of LCK also 25 
requires phosphorylation at Y394 in the activation loop of the kinase domain14,15. In addition, LCK can be 26 
bound by the T-cell coreceptors CD4 and CD8, transmembrane proteins that can both bind to the MHC 27 
protein16 and engage with LCK17,18 through a Zn2+ ‘clasp’19. The functional effect of the coreceptors on T-28 
cell signaling has been extensively studied during thymocyte development16 but it remains unclear whether 29 
they have a direct influence on LCK kinase activity. 30 
Current in vitro methods to investigate how LCK, or indeed any SFK, functions at the molecular level 31 
invariably depend on assaying its kinase activity after removal from the cellular environment. Experiments 32 
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are invariably performed in solution on non-physiological substrates that are unlikely to faithfully replicate 1 
kinase function when normally constrained to the plasma membrane. A recent study did address this latter 2 
issue, by tethering LCK to lipid vesicles14 but this accomplishment required altering the N-terminal 3 
structure of the kinase to anchor it to the bilayer. 4 
Conversely, most in vivo studies of LCK function have been limited by the inability to initiate kinase 5 
activity directly and so normally rely on steady-state measures of catalytic activity that do not provide the 6 
quantitative detail required for a mechanistic understanding. Recent methods have been designed to address 7 
this, principally by inserting chemically- or optically-controlled domains into kinases to allosterically 8 
modulate its activity20–22. This has found some success, although not with LCK, but all require extensive 9 
alterations to the native kinase structure that could interfere sterically with potential protein interactions, 10 
and may not represent the ‘true’ kinase in situ. 11 
Encoding new functionality at specific sites of a protein when expressed in cells, through the use of 12 
genetically encoded unnatural amino acid incorporation23,24 has enabled the in vivo control of protein 13 
function with a precision more commonly associated with in vitro approaches25. By combining this 14 
approach with a cellular reconstitution of proximal TCR triggering with defined components26, we have 15 
developed a direct and quantitative method to assay the kinase activity of native LCK within the cellular 16 
environment. Engineering LCK so that its catalytic activity can be spatio-temporally controlled within live 17 
cells by brief light stimulation provides a new platform for ‘in vivo biochemistry’, which we use to show 18 
that LCK is critically dependent on Y394 phosphorylation in its active site loop for its kinase activity, and 19 
that the T cell coreceptors can enhance LCK function at limiting kinase levels.  20 
Results 21 
Engineering a photo-caged LCK kinase using unnatural amino acid incorporation 22 
To quantitatively investigate LCK kinase function when localized in the plasma membrane of live cells, we 23 
needed precise temporal control over the initiation of its enzymatic activity. We noted that lysine at position 24 
273 (K273) in the active site of human LCK is essential for its enzymatic activity, where mutation of this 25 
residue disrupts ATP binding and substrate phosphate transfer27. We anticipated that engineering control of 26 
substrate binding at this position would provide a mechanism to modulate LCK kinase activity. We used 27 
unnatural amino acid (UAA) mutagenesis to genetically incorporate a photo-caged variant of lysine (pc-28 
Lys) at K273, which can be rapidly uncaged under ultraviolet (~350-400 nm) illumination, leaving a scar-29 
less lysine residue25,28 (Fig. 1a). The pc-Lys residue can be easily accommodated in the active site of LCK 30 
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without alteration to the kinase structure and is expected to sterically occlude ATP binding (Supplementary 1 
Fig. 1a). 2 
Using an UAA system optimized for efficient incorporation in mammalian cells25,29, we expressed human 3 
LCK fused to eGFP with the codon for K273 mutated to the amber stop codon (LCK K273-TAG) in HEK-293T 4 
cells. Cells were transfected with all components required for UAA incorporation, as well as ZAP70 kinase 5 
fused to the mRuby2 fluorophore. Cells transfected in normal medium showed expression of ZAP70 alone, 6 
but the addition of pc-Lys led to the co-expression of photo-caged LCK (LCK*) (Fig. 1b). This confirmed 7 
that in the absence of pc-Lys, translation of LCK K273-TAG was efficiently terminated at the internal stop 8 
codon. We found that ~40% of ZAP70-expressing cells also incorporated pc-Lys into LCK* (Fig. 1c), 9 
which localized correctly to the plasma membrane (Fig. 1d). Western analysis using an anti-LCK antibody 10 
shows that LCK* was expressed at the expected molecular weight (Fig. 1e).  11 
To demonstrate that LCK* was inactive but could be rendered functional by illumination, we used 12 
HEK-293T cells stably expressing the complete TCR complex (HEK-TCR; Supplementary Fig. 2a) and 13 
measured ZAP70 phosphorylation by LCK* upon illumination of the cells. We have previously shown that 14 
LCK shows constitutive activity towards the TCR and other downstream signaling molecules in 15 
HEK-293T26 due to the near-complete absence of inhibitory proteins that normally restrain its activity 16 
(Supplementary Fig. 2b,c). ZAP70 Y319 is a physiological substrate of LCK and is not associated with any 17 
ZAP70 auto-catalytic mechanism30,31, making it a good readout for LCK kinase activity. We first optimized 18 
the length and intensity of the illumination to uncage pc-Lys in LCK* by measuring Y319 phosphorylation 19 
by phospho-Western analysis (Fig. 1f). Blot quantification showed that prior to illumination no 20 
phosphorylation was detectable but 30 s illumination at 12 mW/cm2 could uncage LCK* sufficiently to 21 
cause phosphorylation 15 min post-illumination without signal saturation (Fig. 1g). This condition was 22 
preferred as it limited any cytotoxic effects of high intensity light and allowed us to capture the dynamic 23 
range of the phosphorylation events over the assay time-course. Control experiments confirmed that the 24 
observed Y319 phosphorylation was specific to the activity of LCK* uncaged by 350-400 nm light 25 
illumination. Phosphorylation was not observed when a catalytically inactive variant of LCK (K273R) was 26 
equivalently illuminated, nor when LCK* was illuminated by different wavelengths of light (500-550 nm) 27 
(Supplementary Fig. 1b).  28 
Using this optimized system, we measured the kinetics of LCK* activity by quenching the phosphorylation 29 
reaction at various time points after pc-Lys uncaging. We could now observe the expected increase in Y319 30 
phosphorylation over time (Fig. 1h) and a progress curve of the wildtype enzyme activity in live cells could 31 
be plotted (Fig. 1i). In subsequent experiments, we decreased the density of time points to improve our 32 
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throughput to analyze several LCK* variants simultaneously, which did not compromise the experimental 1 
results (Supplementary Fig. 3a).  2 
Phosphorylation of LCK active site loop is essential for its kinase activity 3 
LCK, like many members of the tyrosine kinase family, has an activation loop within the kinase domain 4 
(Fig. 2a) that must be phosphorylated at a specific tyrosine residue to ensure full enzymatic activity. 5 
However, it remains unresolved whether the unphosphorylated form of LCK retains significant activity in 6 
vivo, given a recent in vitro study that showed only a two-fold increase in kinase activity when the active 7 
site loop was phosphorylated14. We substituted the tyrosine in the activation loop of LCK to phenylalanine 8 
(Y394F), which abolishes its phosphorylation. We found that this substitution rendered the kinase 9 
essentially inactive (Fig. 2c), which was not caused by the endogenous expression of the inhibitory kinase 10 
CSK by the HEK-TCR cells (Supplementary Fig. 3b). This suggested that when not phosphorylated at 11 
Y394, LCK activity is almost completely absent when present in its native cellular environment. 12 
Conversely, the Y505F mutation in the C-terminal tail of LCK is known to substantially increase its kinase 13 
activity32,33 by removing CSK-mediated phosphorylation of Y505 that drives intramolecular inhibition, and 14 
this is what we observed (Fig. 2d). To provide a quantitative comparison between the LCK* variants, we 15 
derived the maximal reaction rate from the kinetic data, which should be proportional to the catalytic 16 
activity of the kinase assuming equivalent enzyme and substrate concentrations. This data pointed to the 17 
Y505F mutant having a ~8-fold increased rate compared to wildtype LCK*, whereas the rate for the Y394F 18 
mutant was undetectable (Supplementary Fig. 3c). 19 
We used a complementary assay to provide further evidence for the complete inhibition of LCK in the 20 
absence of Y394 phosphorylation. Prior to Y319 phosphorylation, ZAP70 is recruited to the phosphorylated 21 
ITAMs of the TCR complex at the plasma membrane, an event which also depends on LCK activity. We 22 
used live-cell imaging of ZAP70 recruitment to the cell surface as an alternative means to probe LCK kinase 23 
activity towards the TCR. We used an equivalent transfection strategy as above, but used HEK-TCR cells 24 
expressing higher TCR density (HEK-TCRH) to increase the membrane signal (Supplementary Fig. 2d). As 25 
expected, ZAP70 was initially localized to the cytoplasm but rapidly translocated to the plasma membrane 26 
on uncaging wildtype LCK* (Fig. 2e and Supplementary Video 1). Quantitative image analysis to measure 27 
the relative fluorescence intensity of ZAP70 at the plasma membrane showed that it was efficiently 28 
recruited to the plasma membrane (Fig. 2f). The Y394F mutation of LCK* caused undetectable ZAP70 29 
recruitment (Fig. 2g and Supplementary Video 1). Conversely, the Y505F LCK* variant showed even faster 30 
dynamics (Fig. 2h and Supplementary Video 1), saturating ZAP70 binding within 20 s that subsequently 31 
decreased, presumably due to deleterious effects of the over-active kinase on cell integrity, such as 32 
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membrane blebbing (Supplementary Video 1). Because the kinetics of ZAP70 recruitment to the membrane 1 
did not follow a simple profile, we quantified LCK* activity by determining the time required for half-2 
maximal ZAP70 recruitment, with a shorter time corresponding to increased LCK* function 3 
(Supplementary Fig. 3d). The results from these imaging experiments are in strong agreement with the 4 
conclusions from the phospho-Western experiments.  5 
Intramolecular SH3 interaction restrains LCK kinase activity 6 
The SH2 domain of LCK is known to not only interact with phosphorylated tyrosine motifs in other proteins 7 
but also intramolecularly with phosphorylated Y505, which inhibits LCK activity. The generally agreed 8 
explanation for why the Y505F mutation of LCK enhances catalytic activity compared to the wildtype 9 
kinase is the disruption of this intramolecular inhibition. We wanted to test whether the converse was true; 10 
does disrupting binding by the SH2 domain cause equivalent enhancement of LCK function? The R154K 11 
substitution in the SH2 domain of LCK is known to disable binding of this domain to phosphorylated 12 
polypeptides34. We anticipated that this mutation would mimic the Y505F mutant by releasing 13 
intramolecular inhibition. However, the R154K mutation significantly decreased ZAP70 Y319 14 
phosphorylation to ~25% compared to wildtype (Fig. 3a and Supplementary Fig. 3c), implying that the SH2 15 
domain interaction with binding partners, such as the TCR, is more critical to LCK function than its role in 16 
intramolecular inhibition.  17 
The SH3 domain of LCK can also participate in intramolecular binding with the conserved proline-rich 18 
(PxxP) motif in the linker region, although this interaction is significantly less well characterized compared 19 
to the SH2 interaction. We expected that SH3-mediated intramolecular binding would also restrain LCK* 20 
kinase activity. We first disrupted a key residue (W97A) in the SH3 domain and found that LCK* kinase 21 
activity was substantially increased compared to wildtype LCK* (Fig. 3b). This suggested that, at least 22 
within the transfected HEK-TCR cells, the primary function of the SH3 domain is to inhibit LCK kinase 23 
activity rather than bind another target protein. A prediction from this result is that mutating the proline-24 
rich motif that interacts with the SH3 domain within LCK should have an equivalent effect on the activity 25 
of LCK. Through structural modeling of full length human LCK based on a related kinase, we identified 26 
P232 within the conserved PxxP motif of LCK that should interact with W97 of the SH3 domain 27 
(Supplementary Fig. 3e). Mutating this residue (P232A) dramatically increased LCK* kinase activity 28 
(Fig. 3c). Both W97A and P232A substitutions led to an equivalent increase in LCK* activity that was 29 
quantitatively comparable to the Y505F mutant (Fig. 3d and Supplementary Fig. 3c), suggesting the 30 
primary function of the intramolecular SH3-mediated interaction is to restrain LCK catalytic activity. 31 
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LCK activation by auto-phosphorylation 1 
It has been shown that Y394 in the activation loop of LCK is auto-phosphorylated in trans12,14,35,36 but the 2 
kinetics of this reaction have not been studied in situ. To address this, we first investigated the kinetics of 3 
LCK* Y394 auto-phosphorylation following pc-Lys uncaging. We found that the process occurred at a 4 
much faster rate compared to that of ZAP70 Y319 phosphorylation (Fig. 4a). To confirm that this rapid 5 
auto-phosphorylation was occurring predominantly in trans, we co-expressed wildtype LCK* and a 6 
catalytically-inactive variant of LCK (K273R) in cells and measured the phosphorylation of Y394 in both 7 
forms by LCK* (Fig. 4b). Since LCK (K273R) is devoid of kinase activity, any phosphorylation observed 8 
could only be attributed to the in trans activity of uncaged LCK*, which was indeed the case (Fig. 4c). 9 
However, although the relative rates of Y394 auto-phosphorylation on both kinase variants were very 10 
similar, the absolute level of LCK (K273R) phosphorylation was much lower than when compared to 11 
uncaged LCK* (Fig. 4c), which was not due to differences in their expression (Fig. 4b).  12 
The preceding results suggested that the catalytically-inactive LCK (K273R) was less susceptible to auto-13 
phosphorylation at Y394, perhaps by adopting a conformation where Y394 was less accessible, compared 14 
to the uncaged LCK*. We tested this hypothesis by varying the illumination period used to uncage LCK*. 15 
Cells exposed to shorter illumination would have less uncaged, active LCK*. As predicted, shorter 16 
illumination led to a lower maximal pY394 signal compared to the samples that had been illuminated for 17 
longer (Fig. 4d). If the effect of different illumination periods was to only vary the level of LCK* as an 18 
active enzyme, but not as a ‘substrate’, there would have been differences in the rate of phosphorylation 19 
and not the maximal phosphorylation, but this is not what we observed. We hypothesized that because the 20 
Y505F LCK* mutant should be in a more ‘open’ conformation, it should have increased accessibility of 21 
Y394 and this was exactly what we observed (Fig. 4e). 22 
ZAP70 depends on auto-phosphorylation for activation 23 
Full activation of ZAP70 kinase requires phosphorylation of its activation loop at Y493, in an equivalent 24 
manner to LCK37. Although it is accepted that ZAP70 Y493 phosphorylation requires the presence of active 25 
LCK, it is less clear whether LCK itself directly phosphorylates Y49338,39 or whether this modification 26 
primarily relies on ZAP70 auto-phosphorylation31. We used our LCK* uncaging approach to follow the 27 
kinetics of ZAP70 phosphorylation at both Y319 and Y493. We found that LCK*-mediated Y319 28 
phosphorylation had significantly faster kinetics than Y493 phosphorylation, with a delay evident between 29 
the initiation of ZAP70 Y319 and Y493 phosphorylation (Fig. 5a). We speculated that this difference was 30 
due to Y493 phosphorylation being mediated by ZAP70 auto-phosphorylation rather than LCK*. To 31 
investigate this, we repeated the kinetic assay but now included a kinase-dead version of ZAP70 (K369R). 32 
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Compared to wildtype ZAP70, the catalytically inactive version had a far lower rate of Y493 1 
phosphorylation (Fig. 5b). The data show that the primary kinase responsible for ZAP70 Y493 2 
phosphorylation is ZAP70 itself. 3 
Activity of other SRC-family kinases expressed in T cells 4 
There are nine members of SFK family but only three are expressed at significant levels in T cells: LCK, 5 
FYN and to a lesser extent SRC. While both LCK and FYN play roles during early TCR signaling, it is 6 
believed that LCK is the major kinase involved in TCR-mediated signaling40,41. To test whether this was 7 
because LCK was more efficient at initiating T-cell signaling, we constructed the photo-caged versions of 8 
FYN and SRC by mutating the codons for K299 (FYN*) and K298 (SRC*) to the amber stop codon, in an 9 
equivalent manner as for LCK*. We found that ZAP70 Y319 is phosphorylated by LCK* at a much greater 10 
rate when compared with FYN* or SRC* (Supplementary Fig. 4), demonstrating that ZAP70 is a better 11 
substrate for LCK.  12 
Spatial control of LCK activation using the photo-caged system 13 
To demonstrate that we could both spatially and temporally control over LCK activation, we took advantage 14 
of a cell-cell conjugation system where the TCR on the HEK cells interacted with its specific peptide 15 
(derived from NY-ESO) covalently bound into the MHC protein and expressed on the surface of Raji 16 
B cells, which act as efficient ligand presenting cells26. The inhibitory proteins CD45 and CSK-CBP are 17 
now also expressed in HEK-TCRH cells to prevent TCR triggering outside the conjugate interface, where 18 
cells adhere through co-expression of ICAM-1, which can interact with the integrin LFA-1 on Raji B cells 19 
and the TCR–pMHC interaction itself26. We uncaged LCK* by illuminating a diffraction-limited (<1 µm) 20 
region of the conjugate interface with a 405 nm laser beam, pulsed for 1 ms. This spatio-temporally 21 
localized activation of LCK* initially led to the recruitment of ZAP70 only to this region, before increasing 22 
throughout the cell interface, presumably due to LCK* lateral diffusion (Fig. 6 and Supplementary 23 
Video 2). Fortuitously, the presented LCK*-expressing cell was conjugated to two separate B cells, which 24 
allowed us to confirm the spatial restriction of LCK* uncaging since no ZAP70 was recruited to the 25 
untargeted conjugate interface (Fig. 6 and Supplementary Video 2). To confirm that this conjugate region 26 
nonetheless had the potential to be activated, we subsequently used global illumination and observed 27 
ZAP70 recruitment to the second conjugate interface (Fig. 6). This demonstrated that we could both 28 
spatially and temporally control LCK activation at subcellular and millisecond resolution in live cells.  29 
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Effect of CD4 and CD8 coreceptors on LCK function 1 
It is established that the T-cell coreceptors have a significant influence on thymocyte development and 2 
T-cell activation16, and the interaction between the cytosolic tails of the membrane-bound coreceptors and 3 
the SH4 domain of LCK (Fig. 2a) has been confirmed19,42. In addition to the intracellular LCK interaction, 4 
the coreceptors bind the pMHC protein expressed on antigen-presenting cells. It remains uncertain whether 5 
the coreceptor’s effect on LCK activity is mediated solely by influencing the localization, or dwell time, of 6 
the kinase at the engaged TCR complex, a question which sought to directly address using the approaches 7 
described above. We first used our cell conjugate assay to investigate how CD8 modulates LCK*-mediated 8 
ZAP70 membrane recruitment. LCK* uncaging caused the translocation of ZAP70 to the entire conjugate 9 
site (Fig. 7a and Supplementary Video 3), the kinetics of which were quantified over many conjugates 10 
(Fig. 7b). Repeating the assay using CD8+ HEK-TCRH cells (Supplementary Fig. 2e) now caused an 11 
increased rate of ZAP70 translocation following LCK* uncaging (Fig. 7b and Supplementary Fig. 5a). An 12 
equivalent CD4 assay was not possible because the TCR used is restricted by class-I MHC. 13 
CD8 could enhance LCK activity by simply increasing the kinase density within the conjugate interface. 14 
We did indeed observe increased LCK* in this region, compared to the rest of the plasma membrane, but 15 
this effect was not CD8-dependent (Fig. 7c,d). Instructively, the lipid-modified N-terminus of LCK alone 16 
(Myr-eGFP) was sufficient to replicate the increased LCK* density in the conjugate interface (Fig. 7c,d), 17 
as was a prenylated eGFP (eGFP-CaaX), which rather suggested an alteration to the membrane lipid 18 
environment around the clustered TCR as the primary cause. To test whether coreceptor binding directly 19 
enhanced LCK kinase activity independently from pMHC binding, we repeated the ZAP70 membrane 20 
recruitment assay in unconjugated CD8-expressing HEK-TCRH cells. CD8 expression still enhanced the 21 
activity of LCK* (Fig. 7e and Supplementary Fig. 5b), which we also found for CD4 (Fig. 7f and 22 
Supplementary Fig. 5c), suggesting both coreceptors use a similar mechanism to enhance LCK function.  23 
The possibility remained that the observed results arose from a direct interaction of the coreceptors with 24 
the TCR complex itself, as previously suggested for CD443. To test this hypothesis, we created chimeric 25 
coreceptors (CD86ExCD8Int and CD86ExCD4Int) by substituting their extracellular domains with the 26 
monomer CD8644, whilst maintaining their interaction with LCK. Repeating the ZAP70 recruitment 27 
experiment with these constructs showed that the increased LCK* activity on coreceptor binding could be 28 
entirely attributed to the intracellular LCK* interaction (Fig. 7g,h and Supplementary Fig. 5d,e). 29 
Furthermore, the coreceptor effect on LCK* function was almost completely attenuated when a larger 30 
fraction of LCK* was uncaged (Supplementary Fig. 5f-i), which agrees with previous work that coreceptor 31 




By developing a means to both spatially and temporally activate tyrosine kinases in live cells, we have been 2 
able to quantitatively measure the kinetics of LCK catalytic activity in situ, with a level of control over 3 
kinase activity not readily achievable by conventional in vivo and in vitro approaches, as previously 4 
demonstrated28. In agreement with previous biochemical studies11–13, we found that LCK can adopt a range 5 
of conformations that have a strong influence on its intrinsic kinase activity46. These conformations are 6 
primarily driven by intramolecular interactions mediated by both the regulatory SH2 and SH3 domains. We 7 
showed that the kinase activity of LCK* mutants Y505F, W97A and P232A were quantitatively equivalent 8 
(Fig. 3d and Supplementary Fig. 3c), implying they all biased the kinase structure to the same ‘open’ 9 
conformation. However, the concordance of reciprocal mutations affecting the SH3 intramolecular 10 
interaction (W97A and P232A) was not found for the equivalent SH2 interaction, where the R154K 11 
mutation that disrupted this inhibitory interaction actually led to a decrease in activity. This suggested that 12 
losing the ability of LCK to bind a phosphorylated substrate, likely the TCR itself in our assay, was more 13 
deleterious than decreased inhibition, perhaps because the intermolecular SH2 interaction also stabilizes 14 
the active conformation of the kinase domain47,48.  15 
Phosphorylation of the active site loop of LCK leads to rearrangement and stabilization of the catalytic 16 
residues into their optimal positions, and drives the full activation of the kinase6,7,49. We found that this 17 
phosphorylation was completely indispensable for LCK kinase activity, as the Y394F mutant was 18 
essentially inert in both our in situ assays. This is at odds with a recent in vitro study14 that only found a 19 
two-fold difference on Y394 phosphorylation, which could be explained by the additional constraints 20 
placed on LCK when localized to the plasma membrane. The kinetics of Y394 auto-phosphorylation were 21 
rapid, saturating approximately 1 min after LCK* photo-uncaging, which we hypothesize is required to 22 
ensure a kinetic advantage for LCK activation over the abundant phosphatases such as CD45 that would 23 
antagonize this modification50, as suggested previously12. This result was in striking contrast to the delayed 24 
ZAP70 auto-phosphorylation we measured, which could be rate-limiting in TCR triggering and may have 25 
a role in ligand discrimination through kinetic proofreading. The decreased Y394 phosphorylation on a 26 
kinase-inactive version of LCK (K273R) suggested that LCK in an active open conformation is a better 27 
substrate for auto-phosphorylation at Y394, which is supported by structural data of various inactive states 28 
of SRC kinase domains that show sequestration of Y394 within the active site, preventing its auto-29 
phosphorylation6. A recent study also suggested a negative-feedback loop may control LCK activity 30 
through Y192 phosphorylation by ZAP7051. 31 
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Finally, we found that the T-cell coreceptors have a stimulatory effect on LCK kinase activity even in the 1 
absence of pMHC binding. This effect could be ascribed solely to the intracellular interaction between the 2 
coreceptors and LCK (Fig. 7), a result that cannot easily be explained by current models of coreceptor 3 
function45,52. We speculate that the physical interaction between LCK and the coreceptors induces a 4 
conformational rearrangement that enhances LCK function and implies that the unique SH4 domain of LCK 5 
could also form an intramolecular interaction that restrains kinase activity that is released on coreceptor 6 
binding.  7 
There are naturally caveats to the approaches in this study. Although assaying kinase function within the 8 
cellular context provides a more physiological representation of the environment in situ, this means the 9 
system is less ‘clean’ than true in vitro experiments since endogenous proteins have the potential to affect 10 
our results. We used a non-immune cell-line to mitigate as many of these confounding effects as possible. 11 
Another limitation is that the absolute concentrations of the active enzyme and substrate cannot easily be 12 
determined, forcing us to measure relative rather than absolute enzyme kinetics. The extremely rapid auto-13 
phosphorylation of LCK* at Y394 (Fig. 4) and ZAP70 recruitment to plasma membrane by Y505F LCK* 14 
(Fig. 2e,h) upon uncaging indicate that the presence of pc-Lys within the active site of LCK* did not result 15 
in a gross conformational change of the enzyme and that the observed kinetics reflect the true substrate 16 
phosphorylation kinetics rather than the recovery of kinase conformation upon uncaging.  17 
In summary, our quantitative investigation of LCK kinase activity has provided new insights into how this 18 
important SFK functions, with the conclusions likely to translate to other members of the family. 19 
Furthermore, the effect of the coreceptors on LCK activity we observed showcases the power of measuring 20 
enzyme kinetics in situ, where the modulatory effect of membrane-bound interacting proteins can now be 21 
directly addressed. We demonstrated that this approach could be applied to other members of the SFK 22 
family (Supplementary Fig. 4) and could easily be extended to many other kinases that contain a critical 23 
lysine within their active site, including ZAP70 kinase. Further developments to express the photo-caged 24 
proteins in other more physiological cell-types such as primary T cells are ongoing and will enable us to 25 
perform ‘in vivo’ biochemistry experiments to modulate protein function with unprecedented spatio-26 
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Figure Legends 1 
Figure 1. Engineering of a photo-caged LCK kinase using unnatural amino acid incorporation.  2 
(a) Diagram showing photo-caged lysine (pc-Lys) and the removal of its caging group (red) by ultraviolet 3 
light. 4 
(b) Flow cytometry of HEK cells transfected with ZAP70-mRuby2 and the components required for pc-5 
Lys incorporation into LCK-eGFP (LCK*), grown in the absence or presence of pc-Lys.  6 
(c) Histogram showing percentage of transfected cells (ZAP70+) that expressed LCK*.  7 
(d) Fluorescence micrographs showing localization of LCK* and wildtype LCK-eGFP in HEK cells. Scale 8 
bar, 5 µm.  9 
(e) Western blot of LCK* using LCK-specific antibody. Band at ~82 kDa is LCK* and ~31 kDa is truncated 10 
LCK, terminated at the internal amber stop codon.  11 
(f) Representative blot showing ZAP70 phosphorylation at Y319 using a phospho-specific antibody 12 
(green), and LCK* expression (red). HEK-TCR cells co-expressing LCK* and ZAP70 were illuminated at 13 
different intensities for indicated period. Final lane shows phosphorylation by wildtype LCK-eGFP at 14 
steady-state.  15 
(g) Quantification of blots in f. Intensity of pY319 band was normalized to the corresponding intensity of 16 
LCK* band in each lane, and scaled relative to the normalized value of Y319 phosphorylation by wildtype 17 
LCK (final lane in f). 18 
(h) Representative blot of ZAP70 Y319 phosphorylation by LCK* after photo-uncaging at 12 mW/cm2 for 19 
30 s. Time after initiation of uncaging when cells were flash-frozen is shown.  20 
(i) Quantification of blots in h. ZAP70 Y319 phosphorylation by LCK* as a function of time following 21 
illumination. Data are scaled relative to the final time point.  22 
White dotted lines in blots indicate sections from the same blot presented at different brightness for visual 23 
clarity. Data in g and i were fit using a 3-parameter logistic function, presented as mean ± s.e.m. from 24 
independent experiments (n = 3 in g; 4 in i).  25 
Uncropped blots are shown in Supplementary Data Set 1. 26 
Source data for graphs are in Supplementary Data Set 2. 27 
 28 
Figure 2. Phosphorylation of LCK active site loop is essential for its kinase activity.  29 
(a) Cartoon representation of membrane-bound LCK showing key residues in the regulatory SRC-30 
homology (SH) and kinase domains. Structure shown is based on the closely related kinase HCK (PDB: 31 
1QCF) and Phyre2-modeled SH4 domain of LCK. Numbering is based on human LCK sequence. (b-d) 32 
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Plots of ZAP70 Y319 phosphorylation kinetics by wildtype LCK* (b), Y394F LCK* (c) and Y505F LCK* 1 
(d), normalized relative to final time point (15 min) of wildtype LCK* (dashed curve). Data were fit using 2 
3-parameter logistic function, and are presented as mean ± s.e.m. from independent experiments (n = 12 in 3 
b; 4 in c and d). (e) Representative microscopy images showing ZAP70 recruitment to the plasma 4 
membrane of HEK-TCRH cells over time by different LCK* proteins, after photo-uncaging at 5 mW/cm2 5 
for 2 s. Scale bar, 5 µm. (f-h) Quantification of microscopy data to measure ZAP70 recruitment to the 6 
plasma membrane over time by wildtype LCK* (n = 4) (f), Y394F LCK* (n = 3) (g) and Y505F LCK* 7 
(n = 4) (h). Data were collected using 4-8 cells per experiment, with data points represent mean and filled 8 
areas represent s.e.m. from independent experiments at each time point. A smoothed line using a moving-9 
average filter is also shown.  10 
Source data for graphs are in Supplementary Data Set 2. 11 
 12 
Figure 3. Intramolecular SH3 interaction restrains LCK kinase activity.  13 
(a-c) Plots of ZAP70 Y319 phosphorylation kinetics by R154K LCK* (a), W97A LCK* (b) and P232A 14 
LCK* (c), normalized relative to final time point (15 min) of wildtype LCK* (dashed curve). (d) ZAP70 15 
Y319 phosphorylation kinetics by wildtype and mutant LCK* kinases are plotted in one graph for direct 16 
comparison. Data were fit using 3-parameter logistic function, and are presented as mean ± s.e.m. from 17 
independent experiments (n = 12 for wildtype LCK*; 4 for mutant LCK*). 18 
Source data for graphs are in Supplementary Data Set 2. 19 
 20 
Figure 4. Active LCK conformation increases substrate availability for auto-phosphorylation at 21 
Y394.  22 
(a) Plot showing kinetics of wildtype LCK* auto-phosphorylation at Y394 after photo-uncaging.  23 
(b) Representative blots showing auto-phosphorylation at Y394 of both wildtype LCK* and untagged 24 
kinase-inactive LCK (K273R) at the indicated time after LCK* uncaging. ZAP70-mRuby2 was not 25 
included in these experiments. Dotted lines indicate sections from the same blot but presented at different 26 
brightness for visual clarity only.  27 
(c) Quantification of blots in b to show kinetics of LCK* and LCK (K273R) auto-phosphorylation at Y394.  28 
(d) Maximal auto-phosphorylation of Y394 achieved by wildtype LCK* by varying uncaging period of 29 
illumination. Separate plots of Y394 auto-phosphorylation were fit to derive the maximum asymptote 30 
values, which were plotted against illumination period.  31 
(e) Kinetics of wildtype LCK* and Y505F LCK* auto-phosphorylation at Y394.  32 
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For all plots except d, data are normalized relative to wildtype LCK* at 1 min and fit by 3-parameter logistic 1 
function, and presented as mean ± s.e.m. from independent experiments (n = 9 in a; 3 in c; 4 in e). For d, 2 
error bars represent 95% confidence interval of estimated parameter value from independent experiments 3 
(n = 3).  4 
Uncropped blot images are shown in Supplementary Data Set 1. 5 
Source data for graphs are in Supplementary Data Set 2. 6 
 7 
 8 
Figure 5. Differential phosphorylation kinetics between Y319 and Y493 of ZAP70.  9 
(a) Plot showing kinetics of ZAP70 phosphorylation at Y319 and Y493 after LCK* photo-uncaging. Data 10 
are normalized relative to final time point (15 min) for each phosphorylation site. 11 
(b) Plot showing kinetics of ZAP70 phosphorylation at Y493 after LCK* uncaging in HEK-TCR cells 12 
expressing wildtype ZAP70-mRuby2, kinase-inactive ZAP70 (K369R)-mRuby2 or mRuby2 alone as a 13 
control. Data are normalized relative to final time point (15 min) of wildtype ZAP70.  14 
All data were fit using 3-parameter logistic function, and are presented as mean ± s.e.m. from independent 15 
experiments (n = 7 in a; 3 in b). 16 
Source data for graphs are in Supplementary Data Set 2. 17 
 18 
Figure 6. Precise spatio-temporal control of LCK kinase activity in live cells. 19 
A single HEK-TCRH cell expressing LCK* and ZAP70-mRuby2 formed two separate conjugates with Raji 20 
B cells (outlined in overlay). Initially, a specific region of the upper conjugate (white arrow in overlay) was 21 
exposed to a focused 405 nm laser pulse to uncage LCK* in that region only, and ZAP70 recruitment to the 22 
region was observed over time. A second, global illumination was applied on the same cells to uncage the 23 
remaining LCK*. Subsequently, ZAP70 recruitment to the lower conjugate was now observed (plus sign 24 
in ZAP70 image). Twenty cells were analyzed over 3 independent experiments that show similar spatio-25 
temporal control of LCK* kinase activity within individual conjugates.  26 
Figure 7. T-cell coreceptors CD4 and CD8 directly enhance LCK activity.  27 
(a) Representative microscopy images of ZAP70 recruitment to conjugate interface between HEK-TCRH 28 
and APCs (Raji B cells) over time after wildtype LCK* photo-uncaging. Colored boxes denote protein 29 
representation in the overlay image, green is LCK* (not shown). Outline of APC is shown as dotted line. 30 
Scale bar, 5 µm. 31 
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(b) Quantification of ZAP70 recruitment to conjugate interface over time, as depicted in a, in HEK-TCRH 1 
and CD8+ HEK-TCRH cells after LCK* uncaging.  2 
(c) Representative microscopy images of accumulation of eGFP-tagged proteins, as illustrated within the 3 
panel, at the interface between HEK-TCRH or CD8+HEK-TCRH and APC. The ‘Myr’ control uses the first 4 
12 amino acids of LCK sequence fused to eGFP to target the fluorophore to the plasma membrane by 5 
myristoylation and palmitoylation. The ‘CaaX’ control uses the C-terminal sequence from K-RAS which 6 
is prenylated to target the fused eGFP to the plasma membrane. Outline of APC is shown as dotted line. 7 
Scale bar, 5 µm. 8 
(d) Ratio of fluorescence intensity of eGFP-tagged protein inside the conjugate region over that outside the 9 
interface in HEK cells. Data are presented as mean ± s.e.m. of 25-45 cells in each condition from 3 10 
independent experiments.  11 
(e-h) Microscopy image quantification showing ZAP70 recruitment to plasma membrane after LCK* 12 
uncaging in the absence or presence of CD8 (e, g), CD4 (f, h), CD86ExCD8Int (g), and CD86ExCD4Int (h) in 13 
HEK-TCRH cells. Cells were exposed to light at 5 mW/cm2 for 2 s (a, b, e-h). Data in b, e-h are normalized 14 
to maximum asymptote values for each dataset. Lines show data smoothed used a moving-average filter, 15 
data points represent mean and filled areas represent s.e.m. from independent experiments (n = 4 for all 16 
conditions), where 4-8 cells were used in each independent experiment. 17 
Source data for graphs are in Supplementary Data Set 2.  18 
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Materials and Methods 1 
Vector constructs  2 
All constructs, unless described otherwise below, were created by amplifying gene sequences using the 3 
polymerase chain reaction (PCR), incorporating MluI and [BamHI-STOP-NotI] restriction sites at the 5ʹ 4 
and 3ʹ ends of the gene, respectively. Following MluI and NotI double digest of the PCR product, it was 5 
ligated into pHR-SIN lentiviral vector. Where required, a gene encoding a fluorescent protein was inserted 6 
in-frame between BamHI and NotI sites. All photo-caged kinase constructs (wildtype and mutant LCK*, 7 
and SRC* and FYN*) were created by mutating the codon encoding for lysine in the active site of the 8 
kinase (K273 in LCK, K298 in SRC and K299 in FYN) to the amber (TAG) stop codon using overlap 9 
extension PCR. SRC* sequence was gene-synthesized (Thermo Fisher Scientific) to remove restriction sites 10 
by synonymous mutations. The modified genes along with gene encoding eGFP were inserted into pHRʹ 11 
vector as described above.  12 
The components required for unnatural amino acid (UAA) incorporation of photo-caged lysine (pc-Lys) in 13 
proteins expressed by mammalian cells have been described previously25,29. Briefly, the orthogonal pair of 14 
tRNACUA (U25C) and aminoacyl-tRNA synthetase required to charge the tRNACUA with photo-caged lysine 15 
(pc-Lys) are encoded within a PiggyBac vector, (U6-PylT*)4-EF1α-PylRS. It contains 4 copies of the tRNA 16 
along with the synthetase, under the control of the U6 and EF1α promoter, respectively. The E55D mutant 17 
of eukaryotic release factor (eRF)-1 was additionally used to increase efficiency of pc-Lys incorporation.  18 
pHR-IFP2.0-CaaX: The IFP2.0 fluorescent protein was fused at the C-terminus to the K-Ras prenylation 19 
sequence (LEKMSKDGKKKKKKSKTKCVIM). The gene was inserted between the BamHI and NotI of 20 
the pHR-SIN vector. 21 
pHCM-CD45RO: The gene for CD45RO (including a N-terminal His tag) was amplified from a published 22 
construct53. The SFFV promoter was replaced with the CMV equivalent. To drive high expression, the 23 
SV40 introns (16S) were synthesized as a GeneArt String and inserted as BssHII-MluI fragment at the 5’-24 
end of CD45RO gene.  25 
pHR-CBP-CSK: The genes for CBP and CSK were amplified from pHR-CBP and pHR-CSK26 and inserted 26 
in-frame into a bicistronic vector with the P2A self-cleaving peptide sequence linking them. 27 
pHR-CD8(βα): The genes for CD8β and CD8α were amplified from gene-synthesized fragments and 28 
inserted in-frame into a bicistronic vector with the P2A self-cleaving peptide sequence linking them. 29 
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pHR-CD86ExCD4Int and pHR-CD86ExCD8Int: The chimeric sequences were gene-synthesized (Thermo 1 
Fisher Scientific) to fuse the extracellular domain of CD86 with the transmembrane domain and cytosolic 2 
tail of CD4 or CD8α. The synthesized genes were inserted into pHR vector as described above. 3 
Cell culture 4 
HEK-TCR and HEK-TCRH cell lines were created by lentiviral transduction of HEK-293T cell line 5 
(purchased from ATCC to ensure identity) to stably express 1G4 TCRαβ chains and CD3γδεζ chains as 6 
previously described26, sorted based on their cell surface expression and made clonal by limiting dilution. 7 
All HEK cell variants were grown in DMEM (Sigma) and Raji B cells (purchased from ATCC) were grown 8 
in RPMI-1640 (Sigma), both supplemented with 10% FCS (Gibco), and 2 mM L-glutamine, 100 U/ml 9 
penicillin and 100 µg/ml Streptomycin (Sigma). All cells were incubated at 37°C, 5% CO2 under full 10 
humidity and tested for mycoplasma contamination using MycoAlert kit (Lonza).  11 
Transient transfection 12 
One day prior to transfection, HEK-293T cells were seeded into 6-well plates or 35 mm poly-L-lysine 13 
coated glass-bottom imaging dishes (MatTek) so that the cells reach 75% confluency on the day of 14 
transfection. For all transfections performed here, a total of 2 µg of DNA per well or dish was transfected 15 
using GeneJuice (Merck) except for transfection of cells used in Fig. 4b,c, which was 1 µg of DNA per 16 
well. Transfected cells were usually analyzed 40-48 h after transfection.  17 
In general, the main components to be transfected into HEK-TCR cells were pHR-LCK*, (U6-PylT*)4-18 
EF1α-PylRS, pcDNA5-eRF1 (E55D) and pHR-ZAP70-mRuby2 at a DNA ratio of 2:2:2:1. Any additional 19 
components were included in the mix with a ratio of 1 while maintaining the total of 2 µg DNA per 20 
transfection. For microscopy experiments of unconjugated HEK cells, pHR-IFP2.0-CaaX was transfected 21 
in addition to the main components to identify plasma membrane. Biliverdin was added to the medium at 22 
6 h after transfection at a final concentration of 20 µM to enhance IFP2.0 fluorescence. For microscopy 23 
experiments of HEK cells conjugated to Raji B cells, additional components of pHCM-CD45RO, pHR-24 
CBP-CSK and pHR-ICAM-1 were transfected in addition to the core LCK* components.  25 
Lentiviral transduction and generation of stable expressing cells 26 
To produce lentivirus, the gene of interest in a lentiviral backbone vector, pCMVΔ8.91 (encoding essential 27 
packaging genes) and pMD2.G (encoding VSV-G gene to pseudotype virus) were transfected into HEK-28 
293T cells at a ratio of 2:2:1. A total of 1.5 µg of DNA was transfected per well using GeneJuice (Merck). 29 
After 48-72 h, the lentivirus-containing medium was collected, centrifuged at 4,300g for 2 min to remove 30 
debris, and incubated with HEK cells to be transduced for 16 h. Fresh medium was then added to the cells 31 
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and expression of the protein of interest was monitored regularly and cell population was expanded. Once 1 
the expression level was stable, the cells were bulk-sorted to isolate cell populations with desired protein 2 
expression level.  3 
Uncaging of LCK* by illumination for Western blot analysis 4 
After transfection for 40-48 h, HEK-TCR cells were trypsinized to detach them from the wells for 5 min at 5 
37°C and neutralized by the addition of an equal volume of fresh medium. Cells were pipetted several times 6 
to obtain a homogenous single-cell suspension and collected in a FACS tube, after an aliquot was removed 7 
for analysis of protein expression by flow cytometry. The rest of the cells were then centrifuged at 800g for 8 
5 min and the supernatant was discarded. Cells were washed once in sterile PBS and resuspended in an 9 
appropriate volume of DMEMgfp2 anti-bleaching medium (Evrogen) supplemented with 10% FCS.  10 
Cells were illuminated with light from an AMH-200 light source (Andor) using a ‘DAPI’ (377±25nm) filter 11 
at 2.5 or 12 mW/cm2 for the specified illumination period. To facilitate this, a custom-designed illumination 12 
chamber was built around a Nikon Ti Epi-FL illuminator so that a tube could be positioned at the focal 13 
point of the illuminator while providing a means to sample the cells during illumination. Aliquots of cell 14 
suspension (50 µl) were collected at defined time intervals in 1.5 ml tubes pre-frozen on a metal block with 15 
dry ice to immediately quench the phosphorylation reaction. An equal volume of 2× lysis buffer [2% 16 
Nonidet P40 (AppliChem), 2 mM sodium orthovanadate (Sigma), 2 mM phenylmethanesulfonylfluoride, 17 
and 2× Complete, EDTA-free protease inhibitor cocktail (Roche) in 2× Tris-buffered saline (40 mM Tris, 18 
300 mM NaCl, pH7.4)] was overlaid on the frozen cell suspension and the samples were let to thaw slowly 19 
on ice. After 1 h incubation on ice with occasional agitation to mix the samples, cell lysates were centrifuged 20 
at 20,000g for 10 min at 4°C. The supernatant fraction was then mixed with LDS sample buffer and 21 
dithiothreitol, and boiled at 95°C for 10 min before analyzed by SDS-PAGE and Western blotting.  22 
Western blotting 23 
SDS-PAGE was performed using NuPAGE Novex 4-12% Bis-Tris Midi protein gels (26 wells) and XCell4 24 
SureLock Midi-Cell Electrophoresis System according to the manufacturer’s instructions (Thermo Fisher 25 
Scientific). Gel transfer to nitrocellulose was performed using the iBlot device (Thermo Fisher Scientific). 26 
The primary antibodies used in this study were: anti-pY319-ZAP70 (cat#: 2701), anti-pY493-ZAP70 (cat#: 27 
2704), anti-pY416-SRC (reacts with LCK pY394; cat#: 2101), anti-LCK (cat#: 2657), anti-SHP-1 (cat#: 28 
3759), anti-SHP 2 (cat#: 3397) and anti-CSK mAb (cat#: 4980), which were all purchased from Cell 29 
Signaling Technology and are all raised in the rabbit except anti-LCK, which is raised in the mouse. Anti-30 
beta actin mAb is raised in mouse (cat#: AB11003; abcam). For the combined detection of LCK*, FYN* 31 
and SRC*, a mouse mAb against eGFP (cat#: A11120; Life Technologies) was used to give equivalent 32 
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sensitivity. All primary antibodies were used at 1:1000 dilution. Secondary antibodies were used at 1:20,000 1 
dilution: anti-rabbit or mouse IgG (H+L) DyLight 800 (cat#: 5151 & 5257; Cell Signaling) and 2 
AlexaFluor 680 goat anti-rabbit or mouse IgG (H+L) (cat#: A21109 & A21058; Life Technologies). The 3 
transferred blot membrane was first blocked with 2.5% non-fat milk (Sigma) in Tris-buffered saline 4 
(MTBS) before incubation with primary antibody in MTBS including 0.1% Tween-20 (MTBS-T) at 4°C 5 
overnight with agitation. The membrane was then washed 3 times in TBS-T, followed by 1 h incubation in 6 
the appropriate secondary antibody at room temperature in MTBS-T before washing 3 times in TBS. 7 
Fluorescent protein bands were visualized using the Odyssey CLx imaging system (LI-COR) that enables 8 
two-color detection at 700 nm and 800 nm on the same blot over a >5-decade linear range.  9 
Flow cytometry 10 
An LSRII flow cytometer (Beckton Dickinson) was used to measure expression levels of proteins in 11 
transfected or transduced HEK cells. For detection of fluorescently-tagged proteins, the cells were washed 12 
once in FACS buffer [5% (v/v) FBS, 0.1% (w/v) NaN3 in PBS, pH 7.4] and fixed in FACS Fix buffer [1.6% 13 
(v/v) formaldehyde, 2% (w/v) glucose, 0.1% (w/v) NaN3 in PBS, pH 7.4] prior to flow cytometry 14 
experiment. For detection of untagged proteins, the primary antibodies used (all from BioLegend) were 15 
AlexaFluor 647-conjugated anti-TCR (cat#: 306714), AlexaFluor 488-conjugated anti-CD4 (cat#: 317419) 16 
or anti-CD8 (cat#: 301024) and an AlexaFluor 647-conjugated anti-CD45 (cat#: 304056) antibody that 17 
recognizes all isoforms. Antibodies were diluted 1:50 in FACS buffer and incubated with the cells for 18 
30 min on ice. Labeled cells were washed with FACS buffer once, cells were centrifuged at 800g for 5 min 19 
and the resuspended pellet fixed in FACS Fix buffer. Routinely, 20,000 live cells gated by scatter were 20 
collected for each analysis.  21 
Cell conjugation 22 
HEK-TCR cells for conjugation experiments were grown and transfected in 6-well plates as described 23 
above. After 40-48 h, cells were trypsinized to detach them from the wells for 5 min at 37°C before 24 
neutralization by the addition of an equal volume of fresh medium. Cells were pipetted several times to 25 
obtain a homogenous single-cell suspension and collected in a 1.5 ml Eppendorf tube. Approximately 1×106 26 
Raji B cells expressing the appropriate pMHC were collected in a separate tube. Both tubes were 27 
centrifuged at 800g for 3 min to pellet the cells. Resuspended pellets were then washed in fresh complete 28 
DMEM and centrifuged again. After this, both pellets were resuspended in residual medium and combined 29 
to a total volume of ~200 µl with medium in a 0.2 ml PCR tube. The cells were incubated in a 37°C water 30 
bath for 30 min to drive cell conjugation. Following incubation, conjugated cells were washed once in 31 
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Dulbecco’s PBS with CaCl2 and MgCl2 (DPBS), resuspended in 1 ml of DMEMgfp2 anti-bleaching medium 1 
(Evrogen) and transferred to a MatTek imaging dish.  2 
Spinning disc confocal microscopy 3 
For imaging of unconjugated HEK cells to study ZAP70-mRuby2 recruitment to plasma membrane, cells 4 
were seeded directly into the imaging dish and transfected as described above. Prior to imaging, cells were 5 
washed gently in DPBS once and 1 ml of imaging medium was added to cover the cells in the dish. All 6 
live-cell imaging experiments in this study used a Nikon Ti inverted microscope in a thermally-controlled 7 
enclosure (OKOLabs), equipped with a CSU-X1 spinning-disc confocal head (Yokogawa). Laser lines used 8 
to excite samples were: 405 nm (100 mW), 488 nm (60 mW), 561 nm (50 mW) and 640 nm (100 mW), 9 
controlled by an acousto-optic tunable filter (Andor). Fluorescence emission was collected through filters 10 
for mTagBFP (460±15 nm), eGFP (525±25 nm), mRuby2 (607±18 nm) and IFP2.0 (708±38 nm). All 11 
images were collected using a Plan Apo VC 100× 1.4 NA oil-immersion objective (Nikon) onto an iXon 12 
Ultra EM-CCD camera (Andor) with a calculated pixel size of 85 nm. Stage movement was controlled by 13 
a Prior motorized stage with a Piezo Z-drive. The entire microscope system was controlled by μManager 14 
software that was used to create multi-channel, multi-time point image data-sets and at multiple positions 15 
when required. The built-in perfect-focus unit of the microscope was used to correct for axial focus drift 16 
due to fluctuations in temperature. 17 
Global photo-uncaging: HEK cells expressing both LCK* and ZAP70-mRuby2 were identified under 18 
microscope based on the expression of the tagged fluorescent proteins. In the cell conjugation experiment, 19 
conjugated cells were identified based on the presence of pMHC-BFP-expressing Raji B cells forming a 20 
cup-shaped contact with LCK* and ZAP70-mRuby2-expressing HEK cells. To follow ZAP70-mRuby2 21 
recruitment to the plasma membrane or cell conjugate interface after LCK* activation, cells were 22 
illuminated by light from an AMH-200 light source (Andor) through a DAPI filter cube (excitation at 23 
377±25 nm) in the microscope. A script was written in μManager software to capture 5-10 images before 24 
photo-uncaging by illuminating cells through the objective at 5 mW/cm2 or 500 mW/cm2 for a duration of 25 
2 s. Following this, images were acquired continuously every ~1.4 s for approximately 2 min. Images from 26 
all relevant fluorescence channels were captured throughout the experiment. Images were analyzed as 27 
described below. Acquisition parameters were set up to ensure the best dynamic range to avoid signal 28 
saturation in the fluorescence channels. Due to variability in the expression of proteins using transient 29 
transfection, individual laser powers were adjusted between experiments while maintaining the exposure 30 
times.  31 
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Focused photo-uncaging: To activate LCK* spatially with subcellular accuracy in the cell-cell conjugate 1 
region, a similar protocol was used as for the global photo-uncaging. To uncage LCK* now though, a 2 
defined diffraction-limited spot in the image was excited with a 405 nm laser at full power (1.2 mW at 3 
objective) using a dwell-time of 100 µs repeated 10 times. Images were subsequently acquired as above. 4 
Data analysis 5 
Western blot images: High resolution Western blot images from the Odyssey imager were acquired as 32-6 
bit grayscale files for quantification with ImageJ software. Equivalent regions of interest (ROIs) were drawn 7 
around the bands of interest to measure the integrated density of each ROI. To express the level of 8 
phosphorylation relative to LCK*, to correct for loading and expression, the density value of the 9 
phosphorylated band was divided by that of the corresponding LCK* band to obtain the relative 10 
phosphorylation of each sample. To allow comparison between experiments, these values were then 11 
normalized according to the figure legends to create a plot of phosphorylation kinetics. For every 12 
experiment, a wildtype dataset was also collected so that different conditions could be directly compared 13 
through this standard. Further processing of the Western blots shown in figures (rotation, cropping and 14 
contrasting) was performed uniformly over images solely for better visualization. Where needed, white 15 
dotted lines denote sections of the same blot with different contrast settings for visual clarity only. Image 16 
quantification, however, always used the values from original image files.  17 
Microscopy images: Processing and quantitative analyses of microscopy images were performed using 18 
scripts written in ImageJ. Data from the ZAP70-mRuby2 channel were corrected for photo-bleaching prior 19 
to quantification, which followed a single-exponential decay process. ROIs were drawn around the cell 20 
edge or the cell conjugate region to measure the signal for ZAP70-mRuby2 recruitment to these regions 21 
over time. To define the plasma membrane ROIs, images from the ZAP70-mRuby2, LCK*, and IFP2.0-22 
CaaX stacks were combined, background subtracted and contrast enhanced to clearly define a cell shape 23 
that could be thresholded to create a binary mask of the cell. This mask was then outlined to describe the 24 
cell edge as a single-pixel width ROI, which was re-mapped to the range [0, 1]. The pixel count in the ROI 25 
was used as the mask area. To draw an ROI in the cell conjugate region, the images from pMHC-BFP 26 
channel were used. Prior to quantification, where needed, image stacks were cropped to isolate the relevant 27 
conjugated cells to remove signal from nearby unconjugated cells. Upon background subtraction, contrast 28 
enhancement and Gaussian smoothing, the conjugate region was thresholded to create a binary mask. This 29 
mask was skeletonized to create a single-pixel width ROI and mapped over [0,1]. The masked images and 30 
corresponding ZAP70-mRuby2 stack were then multiplied to create a stack that only contained the 31 
fluorescence intensity values in the ROI only. To obtain the mean value of mRuby2 intensity in the ROI, 32 
the summed intensities were divided by the ROI area. A similar workflow was performed to obtain the 33 
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mean value of mRuby2 over the entire cell by drawing an ROI of the area bounded by the cell mask. The 1 
mean intensity at the cell edge or conjugate region was divided by the corresponding mean intensity over 2 
the whole cell to obtain the relative fraction for ZAP70 membrane or conjugate recruitment in each image, 3 
plotted against time in the main text. To measure the ratio of eGFP signal inside over outside the conjugate, 4 
line ROIs were drawn manually to define the conjugate region and the edge of eGFP-expressing HEK cells 5 
prior to illumination. Mean intensities of eGFP were then measured at these ROIs. 6 
Quantification of endogenous protein expression: Expression of endogenous CSK, SHP-1 and SHP-2 in 7 
various cell lines were detected by Western blot using monoclonal antibodies specific to the proteins. 8 
Samples were prepared as described for the main experiment and the blots were analyzed as described 9 
above. Three different dilutions of each soluble cell lysate were measured to obtain an average value. Raw 10 
intensity values from the blots were corrected for the dilution factors obtained from the relative expression 11 
of an actin control, cell density in sample and the cytoplasmic volumes of the specific cell lines. These 12 
corrected values for each cytoplasmic protein are then presented as relative values compared to the protein 13 
expression in CD4+ T cells. Cytoplasmic volumes of the different cell lines were 96.1 fL for CD4+ and 14 
CD8+ T cells, 664 fL for Jurkat T cells and 790 fL for HEK293T cells54-56. 15 
Data plotting: All data were initially processed in Excel (Microsoft) to compute the mean and SEM values. 16 
Subsequent data plotting was performed using MATLAB (MathWorks). Where appropriate, data fitting 17 
was performed using a 3-parameter logistic function: 𝑦𝑦 = 𝑑𝑑 �1 − 1
1+�𝑡𝑡𝑐𝑐�
𝑏𝑏�,  where b is the Hill’s 18 
coefficient, c is the inflection point, d is the maximum asymptote and t is time (min).The maximum 19 
asymptote values calculated were used for normalization of the imaging data in Fig. 7, and the derived 95% 20 
confidence interval values were used as the error bar values in Fig. 4d. Otherwise, a moving-average filter 21 
was used to smooth the data points. Error bars were used to represent the s.e.m. of discrete data points in 22 
phosphorylation analyses. Filled area was used to represent the s.e.m. of the more continuous data points 23 
in the ZAP70 recruitment analyses.  24 
Derivation of relative initial rates and time to half-maximal ZAP70 recruitment: Plots from Western 25 
and imaging data were analyzed by MATLAB (MathWorks) further to derive a measure of the rate of LCK 26 
kinase activity in each experiment. For the Western analyses, the reaction rate was estimated by 27 
differentiating the 3-parameter logistic function used to fit the data (see Data Plotting above) with respect 28 
to time. Taking this value at t = 0.5 min defined the initial reaction rate (V0), when this parameter is expected 29 
to be maximal immediately after end of photo-uncaging period. For the imaging experiments, the ZAP70 30 
recruitment datasets were smoothed and normalized to the corresponding maximum values for datasets that 31 
27 
 
had reached saturation or maximum asymptotes for datasets that had not. The normalized data were then 1 
spline-fitted to estimate the time when the recruitment of ZAP70 to the plasma membrane was at half-2 
maximum. In both cases, rate parameters were determined from n number of independent experiments as 3 
indicated in the figure legends, and the mean and s.e.m. values were calculated from these values.  4 
A Life Sciences Reporting Summary for this article is available online. 5 
  6 
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Data Availability Statement 1 
Source data used to generate the graphs are available in Supplementary Data Set 2. Other data that support 2 
the findings of this study (e.g. Western blots, microscopy images and pre-normalization raw values) are 3 
available from the corresponding author J.R.J. upon reasonable request.  4 
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Supplementary Figure 1 
Incorporation of photo-caged lysine (pc-Lys) at K273 of human LCK allows specific control of the enzyme activity. 
(a) Modelling of the kinase domain of LCK with ATP (left) or pc-Lys at position 273 (right) in the native active site, based on a crystal 
structure of the kinase domain alone (1QPC). For the ATP-bound structure, the original AMP-PNP ligand has been modeled as ATP, 
with K273 also shown. For the pc-Lys model, the incorporated unnatural amino acid was built into the active site using PyMol. 
Rendering was performed in Chimera. (b) A representative Western blot to show that the ZAP70 pY319 signal observed is specifically 
due to LCK* uncaging by UV light (350-400 nm). HEK-TCR cells were transfected with WT LCK* or kinase inactive LCK (K273R), 
ZAP70-mRuby2 and the components for pc-Lys incorporation, and illuminated with 350-400 nm or 500-550 nm light for 30 s as 
indicated in the left panel. Right panel shows the quantification of the Western blot, data are normalized relative to final time point 
(15 min) of wildtype LCK* 350-400 nm and are presented as mean ± s.e.m. from independent experiments (n = 3). Uncropped blot 




Supplementary Figure 2 
Expression of proteins in various cell lines. 
(a) Histogram of flow cytometry data showing expression of cell surface TCR in cell lines indicated in the panel using a fluorescently 
conjugated anti-TCRβ antibody. (b) Histogram of flow cytometry data showing expression of endogenous CD45 phosphatase in 
HEK293T and Jurkat T cells using a fluorescently conjugated anti-CD45 antibody. (c) Normalized cytoplasmic densities of CSK, SHP-1 
and SHP-2 expressed endogenously in cell lines indicated in the panels. Protein expression was detected by Western blot using 
monoclonal antibodies specific to the proteins and data are normalized relative to the protein expression in CD4+ T cells. Quantification 
of the Western blot is described in the Materials and Methods. (d-f) Histograms of flow cytometry data showing cell surface expression 
of TCR (d), CD8 (e) and CD4 (f) in various HEK-derived cell lines using fluorescently conjugated antibodies against TCRβ, CD8β or 





Supplementary Figure 3 
Kinase activities of WT and mutant LCK* proteins on ZAP70 phosphorylation and recruitment to plasma membrane after uncaging.  
(a) Plot of ZAP70 Y319 phosphorylation kinetics by wildtype LCK* from two identical sets of experiments with different numbers of time 
points collected, as indicated within the figure. (b) Plot of the kinetics of ZAP70 Y319 phosphorylation by wildtype or Y394F LCK* after 
uncaging, in the presence or absence of dominant negative version of CSK (K222R). Data in a and b are relative to final time point 
(15 min) of wildtype LCK* in each experiment and were fit using a 3-parameter logistic function, and are presented as mean ± s.e.m. 
from independent experiments (n = 4 in a [22 time points], n = 12 in a [6 time points] and n = 3 in b). (c,d) Quantification of the activities 
of wildtype and mutant LCK* kinases derived from the phosphorylation and recruitment kinetic curves. (c) Initial reaction rates (V0) of 
ZAP70 Y319 phosphorylation by LCK* mutants relative to WT LCK* after uncaging (related to Fig. 2b-d and 3a-d). (d) Time to achieve 
half-maximal recruitment of ZAP70 to plasma membrane by WT LCK* or indicated mutants after UV illumination at 5 mW/cm2 (related 
to Fig. 2f-h). For this measure of LCK* reaction rate, a lower value indicates more efficient kinase activity, which was not detectable 
(n.d.) for the Y394F mutant. Data are presented as mean ± s.e.m.  from independent experiments (n = 4). (e) Identification of proline in 
the PxxP motif in the linker region of HCK (PDB ID: 1QCF) that binds intramolecularly to the SH3 domain. The amino acid numbering 





Supplementary Figure 4 
Plot of the kinetics of ZAP70 Y319 phosphorylation by wildtype LCK*, FYN*, or SRC* after uncaging.  
Data are relative to final time point (15 min) of LCK* and were fit using a 3-parameter logistic function. Data are presented as mean ± 




Supplementary Figure 5 
Time to achieve half-maximal recruitment of ZAP70 to phosphorylated ITAMs by wildtype LCK* in the presence of CD4 or CD8 co-
receptors. 
(a) Time to achieve half-maximal recruitment of ZAP70 to conjugate interface by WT LCK* in CD8+ HEK-TCRH and in HEK-TCRH cells 
after UV illumination at 5 mW/cm2 (related to Fig. 7b). For this measure of LCK* reaction rate, a lower value indicates more efficient 
kinase activity. (b,c) Time to achieve half-maximal recruitment of ZAP70 to plasma membrane by WT LCK* in the absence or presence 
of CD8 (b) or CD4 (c) in HEK-TCRH cells after UV illumination at 5 mW/cm2 for 2 s (related to Fig. 7e,f). (d,e) Time to achieve half-
maximal recruitment of ZAP70 to plasma membrane by WT LCK* in CD8+ and CD86ExCD8Int+ (d), or CD4+ and CD86ExCD4Int+ (e) 
HEK-TCRH cells relative to that in HEK-TCRH cells after UV illumination at 5 mW/cm2 for 2 s (related to Fig. 7g,h). (f,g) Microscopy 
image quantification showing ZAP70 recruitment to plasma membrane after LCK* uncaging in the presence or absence of CD8 (f) or 
CD4 (g) in HEK-TCRH cells after UV illumination at 500 mW/cm2 for 2 s. Data are normalized to maximum asymptote values for each 
dataset. Lines show data smoothed used a moving-average filter, data points represent mean and filled areas represent s.e.m. from 
independent experiments (n = 3), where 4-8 cells were used in each independent experiment. (h,i) Time to achieve half-maximal 
recruitment of ZAP70 to plasma membrane by WT LCK* in the absence or presence of CD8 (h) or CD4 (i) in HEK-TCRH cells after UV 
illumination at 500 mW/cm2 for 2 s (related to Supplementary Fig. 5f,g). Data in a-e,h,i are presented as mean ± s.e.m. from 
independent experiments (n=4 in a-c; 3 in d,e,h,i). 
 
